caffeine (Compound)

Synonyms:caffeine, 58-08-2, Guaranine, 1,3,7-Trimethylxanthine, Methyltheobromine, Theine, Thein, Cafeina, Koffein, Mateina, Alert-pep, Caffein, Cafipel, Coffeine, Refresh'n, Caffedrine, Vivarin, Anhydrous caffeine, Stim, Cafamil, Cafecon, Caffine, Dexitac, Nodaca, No-Doz, Eldiatric C, 7-Methyltheophylline, Durvitan, Hycomine, Organex, Nix Nap, Methyltheobromide, Coffeinum, Coffein, Phensal, 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione, Caffeine, synthetic, 1,3,7-Trimethylpurine-2,6-dione, Quick-Pep, Synalgos, Tirend, 1,3,7-Trimethyl-2,6-dioxopurine, Theophylline, 7-methyl, DHCplus, Tri-Aqua, Kofein, Miudol, 1H-Purine-2,6-dione, 3,7-dihydro-1,3,7-trimethyl-, Caffeine, anhydrous, Theobromine, 1-methyl-, Propoxyphene Compound 65, Kofein [Czech], Coffein [German], Koffein [German], 1-methyltheobromine, Caffeine (natural), Xanthine, 1,3,7-trimethyl, Caffeina [Italian], Theophylline Me, Methylxanthine theophylline, Theobromine Me, 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione, NCI-C02733, SK-65 Compound, Anacin, Anacin Maximum Strength, CAFFEINE ANHYDROUS, FEMA No. 2224, P-A-C Analgesic Tablets, C8H10N4O2, HSDB 36, 1,3,7-trimethyl-2,3,6,7-tetrahydro-1H-purine-2,6-dione, Caffeinum, BRN 0017705, NSC 5036, A.S.A. and Codeine Compound, 1,3,7-trimethyl-1H-purine-2,6(3H,7H)-dione, AI3-20154, NSC-5036, CHEMBL113, Caffeine melting point standard, CFF, DTXSID0020232, CHEBI:27732, CAFFEINE(3-METHYL-13C), 3G6A5W338E, MFCD00005758, caffenium, SK 65 Compound, Caffeina, Caffeine [BAN:JAN], CAFFEINE-D3, DTXCID40232, 202282-98-2, cafeine, teina, CAS-58-08-2, Caffeine (USP), SMR000326667, CCRIS 1314, SR-01000075187, Anhydrous caffeine (TN), EINECS 200-362-1, Monomethyl derivative of Theophylline, Caffeine [USP:BAN:JAN], Anhydrous caffeine (JP15), UNII-3G6A5W338E, Caffeine hydrous, 1gfz, Caffeine, BioXtra, TNP00310, Monohydrate Caffeine, Respia (TN), 1-methyl-Theobromine, 7-methyl Theophylline, Cafergot (Salt/Mix), 1,7-Trimethylxanthine, Spectrum_001301, 1l5q, 1l7x, 2a3b, 3g6m, 3,7-dihydro-1,3,7-trimethyl-1H-purine, CAFFEINE [FHFI], CAFFEINE [HSDB], CAFFEINE [IARC], CAFFEINE [INCI], CAFFEINE [FCC], Xanthine,3,7-trimethyl, CAFFEINE [II], CAFFEINE [MI], Theine, methyltheobromine, CAFFEINE [VANDF], CAFFEINUM [HPUS], 1,3,7-Trimethylxantine, Spectrum2_001261, Spectrum3_000321, Spectrum4_001782, Spectrum5_000423, Lopac-C-0750, CAFFEINE [MART.], bmse000206, CAFFEINE [USP-RS], CAFFEINE [WHO-DD], CAFFEINE [WHO-IP], MolMap_000054, Probes1_000150, Probes2_000128, C 0750, EC 200-362-1, SCHEMBL5671, Anhydrous caffeine (JP17), NCIOpen2_008255, BIDD:PXR0172, Lopac0_000228, 1, 3, 7-Trimethylxanthine, BSPBio_001921, GTPL407, KBioGR_002325, KBioSS_001781, 1,3,7-trimethyl-1,3,7-trihydropurine-2,6-dione, 5-26-13-00558 (Beilstein Handbook Reference), MLS001055341, MLS001056714, MLS001066409, BIDD:ER0554, BIDD:GT0632, DivK1c_000730, SPECTRUM1500155, CU-01000012617-3, SPBio_001222, CAFFEINE [ORANGE BOOK], ESGIC COMPONENT CAFFEINE, TRIAD COMPONENT CAFFEINE, MEGxp0_001350, CAFFEINE [EP MONOGRAPH], DIMENHYDRINATE IMPURITY C, FEMCET COMPONENT CAFFEINE, TREZIX COMPONENT CAFFEINE, 1,3,7-trimethyl-2,6-dioxo-1,2,3,6-tetrahydropurine, ANHYDROUS CAFFEINE [JAN], CAFFEINE [USP MONOGRAPH], component of Dilone (Salt/Mix), 1,7-Trimethyl-2,6-dioxopurine, ACon1_000085, ANOQUAN COMPONENT CAFFEINE, BDBM10849, HMS502E12, KBio1_000730, KBio2_001781, KBio2_004349, KBio2_006917, KBio3_001141, Caffeine 1.0 mg/ml in Methanol, COFFEINUM [WHO-IP LATIN], NSC5036, CAFERGOT COMPONENT CAFFEINE, Caffeine, powder, ReagentPlus(R), component of Percodan (Salt/Mix), EXCEDRIN COMPONENT CAFFEINE, FIORICET COMPONENT CAFFEINE, FIORINAL COMPONENT CAFFEINE, MIGERGOT COMPONENT CAFFEINE, NINDS_000730, NORGESIC COMPONENT CAFFEINE, WIGRAINE COMPONENT CAFFEINE, Bio1_000473, Bio1_000962, Bio1_001451, CAFFEINE COMPONENT OF ESGIC, CAFFEINE COMPONENT OF TRIAD, DHC PLUS COMPONENT CAFFEINE, HMS1920I09, HMS2091O11, HMS2232M13, HMS3260N17, HMS3372J18, HMS3435F10, HMS3715D13, Pharmakon1600-01500155, INVAGESIC COMPONENT CAFFEINE, LANORINAL COMPONENT CAFFEINE, NoDoz Caplets and Chewable Tablets, Caffeine 10 microg/mL in Methanol, CAFFEINE ANHYDROUS [WHO-IP], CAFFEINE COMPONENT OF FEMCET, CS-M0795, CAFFEINE COMPONENT OF ANOQUAN, Tox21_201685, Tox21_300010, Tox21_500228, caffeine (1,3,7-trimethylxanthine), Caffeine 100 microg/mL in Methanol, CCG-38825, HB2846, NSC755917, ORPHENGESIC COMPONENT CAFFEINE, PDSP1_001016, PDSP1_001235, PDSP2_001000, PDSP2_001219, STK177283, CAFFEINE COMPONENT OF CAFERGOT, CAFFEINE COMPONENT OF DHC PLUS, CAFFEINE COMPONENT OF EXCEDRIN, CAFFEINE COMPONENT OF FIORICET, CAFFEINE COMPONENT OF FIORINAL, CAFFEINE COMPONENT OF MIGERGOT, CAFFEINE COMPONENT OF NORGESIC, CAFFEINE COMPONENT OF WIGRAINE, Propoxyphene Compound 65 (Salt/Mix), SYNALGOS-DC COMPONENT CAFFEINE, AKOS000121334, CAFFEINE COMPONENT OF INVAGESIC, CAFFEINE COMPONENT OF LANORINAL, 5-26-13-00558 (Beilstein), Bayer Select Headache Pain (Salt/Mix), Caffeine, anhydrous, 99%, FCC, FG, DB00201, LP00228, NSC-755917, SDCCGMLS-0064595.P001, SDCCGMLS-0064595.P002, SDCCGSBI-0050216.P005, CAFFEINE COMPONENT OF ORPHENGESIC, IDI1_000730, MEDIGESIC PLUS COMPONENT CAFFEINE, SYNALGOS-DC-A COMPONENT CAFFEINE, 3,3,7-trimethyl-1H-purine-2,6-dione, CAFFEINE COMPONENT OF SYNALGOS-DC, DARVON COMPOUND COMPONENT CAFFEINE, INVAGESIC FORTE COMPONENT CAFFEINE, NCGC00015208-01, NCGC00015208-02, NCGC00015208-03, NCGC00015208-04, NCGC00015208-05, NCGC00015208-06, NCGC00015208-07, NCGC00015208-08, NCGC00015208-10, NCGC00015208-11, NCGC00015208-12, NCGC00015208-13, NCGC00015208-14, NCGC00015208-15, NCGC00015208-16, NCGC00015208-17, NCGC00015208-18, NCGC00015208-20, NCGC00015208-29, NCGC00090699-01, NCGC00090699-02, NCGC00090699-03, NCGC00090699-04, NCGC00090699-05, NCGC00090699-06, NCGC00090699-07, NCGC00090699-08, NCGC00090699-09, NCGC00168808-01, NCGC00168808-02, NCGC00254057-01, NCGC00259234-01, NCGC00260913-01, 95789-13-2, AC-12774, AS-15340, Caffeine, SAJ special grade, >=98.5%, component of P-A-C Compound (Salt/Mix), CAFFEINE COMPONENT OF SYNALGOS-DC-A, component of A.S.A. Compound (Salt/Mix), ORPHENGESIC FORTE COMPONENT CAFFEINE, SBI-0050216.P004, CAFFEINE COMPONENT OF MEDIGESIC PLUS, DB-023002, WLN: T56 BN DN FNVNVJ B1 F1 H1, C2042, CAFFEINE COMPONENT OF DARVON COMPOUND, CAFFEINE COMPONENT OF INVAGESIC FORTE, EU-0100228, FT-0664195, THEOPHYLLINE IMPURITY A [EP IMPURITY], CAFFEINE COMPONENT OF ORPHENGESIC FORTE, EN300-21663, BIM-0050216.0001, C07481, D00528, DIMENHYDRINATE IMPURITY C [EP IMPURITY], PENTOXIFYLLINE IMPURITY F [EP IMPURITY], Q60235, 1,3,7-trimethyl-3,7-dihydropurine-2,6-dione, 1H-Purine-2, 3,7-dihydro-1,3,7-trimethyl-, AB00051930-09, AB00051930_10, Caffeine, purum, anhydrous, >=99.0% (HPLC), 3,7-dihydro-1,3,7-trimethyl-1H-purine (9CI), Caffeine, anhydrous, tested according to Ph.Eur., L000155, 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion, Caffeine, Sigma Reference Standard, vial of 250 mg, SR-01000075187-1, SR-01000075187-4, SR-01000075187-7, SR-01000075187-8, BRD-K02404261-001-02-7, BRD-K02404261-001-03-5, BRD-K02404261-001-07-6, Caffeine, certified reference material, TraceCERT(R), Caffeine, meets USP testing specifications, anhydrous, Melting point standard 235-237C, analytical standard, 1,3,7-Trimethyl-3,7-dihydro-1H-purine-2,6-dione #, Caffeine, British Pharmacopoeia (BP) Reference Standard, Caffeine, European Pharmacopoeia (EP) Reference Standard, F3371-0262, THEOPHYLLINE MONOHYDRATE IMPURITY A [EP IMPURITY], Z104507896, 07E4FB58-FD79-4175-8E3D-05BF96954522, 3,7-Dihydro-1,3,7-trimethyl-1H-purin-2,6-dion (coffein), Caffeine, United States Pharmacopeia (USP) Reference Standard, Caffeine, Pharmaceutical Secondary Standard; Certified Reference Material, Caffeine for system suitability, European Pharmacopoeia (EP) Reference Standard, Caffeine melting point standard, United States Pharmacopeia (USP) Reference Standard, 114303-55-8, Caffeine Melting Point Standard, Pharmaceutical Secondary Standard; Certified Reference Material, Mettler-Toledo Calibration substance ME 18872, Caffeine, analytical standard, for the calibration of the thermosystem 900, traceable to primary standards (LGC)
Pubchem:PUBCHEM:2519
Id:1d873ca7-ba74-5e2b-b663-ccd81da3a492
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View caffeine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for caffeine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with caffeine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.